Detalhe da pesquisa
1.
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.
Pediatr Blood Cancer
; 67(10): e28417, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729196